Reduced expression of IL-12 p35 by SJL/J macrophages responding to Theiler's virus infection is associated with constitutive activation of IRF-3

Virology

Volumn 353, Issue 2, 2006, Pages 422-432

  Dahlberg, Angela ^a   Auble, Mark R ^a   Petro, Thomas M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

B10.S; IL 12; IRF 3; Macrophages; SJL J; TLR3; TLR7; TMEV

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; LOXORIBINE; PROTEIN P35; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; MACROPHAGE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; VIRUS INFECTION;

ANIMALS; CARDIOVIRUS INFECTIONS; CELL LINE; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DOWN-REGULATION; FEMALE; INTERFERON REGULATORY FACTOR-3; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P35; MACROPHAGES; MICE; MICE, INBRED STRAINS; PROTEIN SUBUNITS; THEILOVIRUS; TIME FACTORS;

THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 33748690758     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.034     Document Type: Article

References (59)

1. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-[kappa]B by Toll-like receptor 3. Nature 413 (2001) 732-738
2. Aubagnac S., Brahic M., and Bureau J.F. Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection. J. Virol. 76 11 (2002) 5807-5812
3. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnaik A.K., Archer D.R., and Barber G.N. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 1 (2000) 129-141
4. Barber S.A., Fultz M.J., Salkowski C.A., and Vogel S.N. Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages. Infect. Immun. 63 2 (1995) 601-608
5. Barnes B.J., Moore P.A., and Pitha P.M. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276 26 (2001) 23382-23390
6. Becher B., Durell B.G., and Noelle R.J. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 112 8 (2003) 1186-1191
7. Cousens L.P., Peterson R., Hsu S., Dorner A., Altman J.D., Ahmed R., and Biron C.A. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 189 8 (1999) 1315-1328
8. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., and Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 6924 (2003) 744-748
9. Delhaye S., van Pesch V., and Michiels T. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78 8 (2004) 4357-4362
10. De Rossi A., D'Andrea E., Colombatti A., Fischinger P.J., and Chieco-Bianchi L. Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. J. Natl. Cancer Inst. 67 6 (1981) 1241-1250
11. Devergne O., Hummel M., Koeppen H., Le Beau M.M., Nathanson E.C., Kieff E., and Birkenbach M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70 2 (1996) 1143-1153
12. Devergne O., Birkenbach M., and Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. U.S.A. 94 22 (1997) 12041-12046
13. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 5663 (2004) 1529-1531
14. Ehl S., Bischoff R., Ostler T., Vallbracht S., Schulte-Monting J., Poltorak A., and Freudenberg M. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 34 4 (2004) 1146-1153
15. Falvo J.V., Parekh B.S., Lin C.H., Fraenkel E., and Maniatis T. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation. Mol. Cell. Biol. 20 13 (2000) 4814-4825
16. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., Monks B., Pitha P.M., and Golenbock D.T. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198 7 (2003) 1043-1055
17. Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E.E., Trinchieri G., Caux C., and Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201 9 (2005) 1435-1446
18. Goriely S., Molle C., Nguyen M., Albarani V., Haddou N.O., Lin R., De Wit D., Flamand V., Willems F., and Goldman M. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 107 3 (2006) 1078-1084
19. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., and Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169 12 (2002) 7104-7110
20. Gran B., Zhang G.X., and Rostami A. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit. Rev. Immunol. 24 2 (2004) 111-128
21. Haahr S., Plesner A.M., Vestergaard B.F., and Hollsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol. Scand. 109 4 (2004) 270-275
22. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., and Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260 5107 (1993) 547-549
23. Janssens S., and Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16 4 (2003) 637-646
24. Karpova A.Y., Ronco L.V., and Howley P.M. Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3. Mol. Cell. Biol. 21 13 (2001) 4169-4176
25. Knobler R.L., Haspel M.V., and Oldstone M.B. Mouse hepatitis virus type 4 (JHM strains) induced fatal central nervous system disease. I. Genetic control and murine neuron as the susceptible site of disease. J. Exp. Med. 153 4 (1981) 832-843
26. Kollet J.I., and Petro T.M. IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol. Immunol. 43 (2006) 623-633
27. Kollet J., Witek C., Gentry J.D., Liu X., Schwartzbach S.D., and Petro T.M. Deletional analysis of the murine IL-12 p35 promoter comparing IFN-gamma and lipopolysaccharide stimulation. J. Immunol. 167 10 (2001) 5653-5663
28. Lin R., Mamane Y., and Hiscott J. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 19 4 (1999) 2465-2474
29. Lipton H.L., Kumar A.S., and Trottier M. Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes. Virus Res. 111 2 (2005) 214-223
30. Lodmell D.L. Genetic control of resistance to street rabies virus in mice. J. Exp. Med. 157 2 (1983) 451-460
31. Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24 8 (2004) 439-454
32. Marie I., Durbin J.E., and Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17 22 (1998) 6660-6669
33. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., and Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11 3 (2005) 335-339
34. Monteyne P., Bihl F., Levillayer F., Brahic M., and Bureau J.F. The Th1/Th2 balance does not account for the difference of susceptibility of mouse strains to Theiler's virus persistent infection. J. Immunol. 162 12 (1999) 7330-7334
35. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., Caligiuri M.A., Durbin J.E., and Biron C.A. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169 8 (2002) 4279-4287
36. Njenga M.K., Coenen M.J., DeCuir N., Yeh H.Y., and Rodriguez M. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis. J. Neurosci. Res. 59 5 (2000) 661-670
37. Oleszak E.L., Chang J.R., Friedman H., Katsetos C.D., and Platsoucas C.D. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 17 1 (2004) 174-207
38. Olson J.K., Croxford J.L., Calenoff M.A., Dal Canto M.C., and Miller S.D. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108 2 (2001) 311-318
39. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 5 (2000) 715-725
40. Ozato K., Tsujimura H., and Tamura T. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques Suppl. (2002) 66-68 (70, 72 passim)
41. Pahan K., Sheikh F.G., Liu X., Hilger S., McKinney M., and Petro T.M. Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J. Biol. Chem. 276 11 (2001) 7899-7905
42. Petro T.M. Disparate expression of IL-12 by SJL/J and B10.S macrophages during Theiler's virus infection is associated with activity of TLR7 and mitogen-activated protein kinases. Microbes Infect. 7 2 (2005) 224-232
43. Salkowski C.A., Kopydlowski K., Blanco J., Cody M.J., McNally R., and Vogel S.N. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 163 3 (1999) 1529-1536
44. Sayetta R.B. Theories of the etiology of multiple sclerosis: a critical review. J. Clin. Lab. Immunol. 21 2 (1986) 55-70
45. Schafer S.L., Lin R., Moore P.A., Hiscott J., and Pitha P.M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273 5 (1998) 2714-2720
46. Servant M.J., Grandvaux N., and Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharmacol. 64 5-6 (2002) 985-992
47. Siren J., Pirhonen J., Julkunen I., and Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J. Immunol. 174 4 (2005) 1932-1937
48. Sundstrom P., Juto P., Wadell G., Hallmans G., Svenningsson A., Nystrom L., Dillner J., and Forsgren L. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62 12 (2004) 2277-2282
49. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S., Honda K., Ohba Y., Mak T.W., and Taniguchi T. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 7030 (2005) 243-249
50. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17 1 (2005) 1-14
51. van Pesch V., van Eyll O., and Michiels T. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75 17 (2001) 7811-7817
52. Vigneau S., Rohrlich P.S., Brahic M., and Bureau J.F. Tmevpg1, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon. J. Virol. 77 10 (2003) 5632-5638
53. Walsh E.C., Guschwan-McMahon S., Daly M.J., Hafler D.A., and Rioux J.D. Genetic analysis of multiple sclerosis. J. Autoimmun. 21 2 (2003) 111-116
54. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., and Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1 4 (1998) 507-518
55. Welton A.R., Chesler E.J., Sturkie C., Jackson A.U., Hirsch G.N., and Spindler K.R. Identification of quantitative trait loci for susceptibility to mouse adenovirus type 1. J. Virol. 79 17 (2005) 11517-11522
56. Wichmann D., Grone H.J., Frese M., Pavlovic J., Anheier B., Haller O., Klenk H.D., and Feldmann H. Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice. J. Virol. 76 17 (2002) 8890-8899
57. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R.M., et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146 9 (1991) 3074-3081
58. Woodroofe M.N., Bellamy A.S., Feldmann M., Davison A.N., and Cuzner M.L. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J. Neurol. Sci. 74 2-3 (1986) 135-152
59. Yang H., Ma G., Lin C.H., Orr M., and Wathelet M.G. Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-beta gene promoter. Eur. J. Biochem. 271 18 (2004) 3693-3703